Favorable patient acceptance of ambulatory blood pressure monitoring in a primary care setting in the United States: a cross-sectional survey

Table 1 Demographics of the population undergoing ABPM testing one or more times during the analysis period (n = 245).

Age (in years)
Mean ± SD	52.6 ± 16.3
(Range)	(17–86)
Gender
Female	119 (49%)
Male	126 (51%)
Indication for ABPM^a
Evaluation of blood pressure control	71 (29%)
Borderline hypertension^b	62 (25%)
Suspected white-coat hypertension	60 (24%)
Treatment resistance	19 (8%)
Other	33 (13%)
Outcome Resulting from ABPM^a
Medication initiated	51 (21%)
Diagnosed white-coat hypertension	49 (20%)
No change in therapy (blood pressure controlled)	37 (15%)
Medication changed	31 (13%)
Dose/regimen adjusted	21 (9%)
Recommend lifestyle modifications	14 (6%)
Other/unknown	42 (18%)

^a categories are mutually exclusive ^b defined as those patients with office blood pressures that are elevated into the Stage 1 range at some visits, but also in the pre-hypertension range (per JNC-VII classification – ref. [10]) at other visits. These patients are untreated and have not been officially diagnosed with hypertension.

ISSN: 2731-4553